Skip to main content

Table 2 Jadad Scoring for quality assessment of included trials

From: Effects of dapagliflozin in the progression of atherosclerosis in patients with type 2 diabetes: a meta-analysis of randomized controlled trials

Trials

Randomisation mentioned

Concealment of randomisation

Blinding

Appropriate blinding method

Reporting of withdrawals

Jadad score

Bays (2017)

Unclear

Yes

Yes

Unclear

Yes

3

Cahn (2021)

Unclear

Yes

Yes

Unclear

Yes

3

Fadini (2017)

Unclear

Yes

No

No

Yes

3

Faerch (2021)

Unclear

Unclear

No

No

Yes

1

Hardy (2013)

Unclear

Unclear

Yes

Unclear

No

1

Jiang (2021)

Unclear

Unclear

Yes

Unclear

Yes

2

Leiter (2016)

Unclear

Unclear

Yes

Yes

Yes

3

Nur Aisyah (2020)

Unclear

Unclear

Yes

Unclear

Yes

2

Papadopoulou (2021)

Unclear

Unclear

Yes

Yes

Yes

3

Shigiyama (2017)

Yes

Yes

Yes

Yes

Yes

5

Sugiyama (2018)

Unclear

Unclear

No

No

Yes

1

Weber (2016)

Yes

Unclear

Yes

Yes

Yes

3